These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11379545)

  • 1. A potential new therapy for sepsis: learning from experience.
    Burnham E; Moss M
    Crit Care Med; 2001 Mar; 29(3):690-1. PubMed ID: 11379545
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.
    Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y
    Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine blockade in sepsis--Are two better than one?
    Hotchkiss RS; Karl IE
    Crit Care Med; 2001 Mar; 29(3):671-2. PubMed ID: 11373443
    [No Abstract]   [Full Text] [Related]  

  • 4. The physiologic basis for anticytokine clinical trials in the treatment of sepsis.
    Cain BS; Meldrum DR; Harken AH; McIntyre RC
    J Am Coll Surg; 1998 Mar; 186(3):337-50. PubMed ID: 9510266
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of FR167653 on pulmonary ischemic reperfusion injury in rats].
    Otani Y; Takeyoshi I; Iino Y; Yokoe T; Matsumoto K; Sato S; Muramoto M; Morishita Y
    Nihon Geka Gakkai Zasshi; 1997 Oct; 98(10):893. PubMed ID: 9490379
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved clinical survival from sepsis.
    Freeman BD; Buchman TG
    J Am Coll Surg; 1998 Mar; 186(3):350-1. PubMed ID: 9510267
    [No Abstract]   [Full Text] [Related]  

  • 7. Targets for sepsis therapies: tumor necrosis factor versus interleukin-1.
    Russell DA; Thompson RC
    Curr Opin Biotechnol; 1993 Dec; 4(6):714-21. PubMed ID: 7764470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking interleukin-1 and tumor necrosis factor in disease.
    Dinarello CA
    Eur Cytokine Netw; 1997 Sep; 8(3):294-6. PubMed ID: 9346365
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of FR167653 on pulmonary ischemia-reperfusion injury: administration timing.
    Takeyoshi I; Otani Y; Koibuchi Y; Yokoe T; Iino Y; Matsumoto K; Muramoto M; Satoh S; Morishita Y
    Transplant Proc; 1999 Aug; 31(5):1935-6. PubMed ID: 10455922
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
    Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of FR167653 on pulmonary ischemia-reperfusion injury in dogs.
    Kamoshita N; Takeyoshi I; Ohwada S; Iino Y; Morishita Y
    J Heart Lung Transplant; 1997 Oct; 16(10):1062-72. PubMed ID: 9361249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of TNF-alpha and IL-1beta production inhibitor,FR167653 on reperfusion injuries--experiment with preserved heart transplantation].
    Koyano T; Takahashi T; Takeyoshi I; Hasegawa Y; Sato Y; Kobayashi S; Murakami J; Ishikawa S; Matsumoto K; Morishita Y
    Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):795. PubMed ID: 9446025
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats.
    Wei YH; Li Y; Qiang CJ
    Int Immunopharmacol; 2004 Dec; 4(13):1625-32. PubMed ID: 15454115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of mice and MODS, TNF-alpha, and sepsis.
    Puri VK
    Crit Care Med; 1998 Jul; 26(7):1160. PubMed ID: 9671361
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of underlying mechanism and genotype on outcome of sepsis trials.
    McIntyre L; Walley KR
    Crit Care Med; 2001 Mar; 29(3):677-9. PubMed ID: 11373447
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuation of microcirculatory disturbance after liver ischemia by newly synthesized inflammatory cytokine suppressor, FR167653.
    Takiguchi M; Totsuka E; Umehara M; Ono H; Nara M; Nozaki T; Wajima N; Takahashi K; Narumi S; Hakamada K; Sugai M; Sasaki M
    Hepatogastroenterology; 2003; 50(51):789-93. PubMed ID: 12828086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 'alphabet' of rheumatoid arthritis treatment.
    Capriotti T
    Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
    [No Abstract]   [Full Text] [Related]  

  • 19. Setting the cytokine trap for autoimmunity.
    Dinarello CA
    Nat Med; 2003 Jan; 9(1):20-2. PubMed ID: 12514715
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiological role of cytokines in congestive heart failure.
    Blum A; Miller H
    Annu Rev Med; 2001; 52():15-27. PubMed ID: 11160765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.